{"podcast":{"title":"Few & Far Between: How Biotech Gets Built","slug":"few-far-between-how-biotech-gets-built-4067896","podcast_index_feed_id":4067896,"rss_url":"https://feeds.castos.com/kd1o1","website_url":"https://biorasi.com/few-far-between-podcast/","image_url":"https://episodes.castos.com/6026d270a471b8-76273800/images/podcast/covers/c1a-7krkv-5zqr8dopfxo9-ndltai.jpg","author":"Adam Gottlieb","episode_count":35,"summary":"Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896"},"episode":{"title":"Episode 47 - Marc Lajoie, CEO at Outpace Bio","slug":"episode-47-marc-lajoie-ceo-at-outpace-bio","published_at":"2024-12-31T10:11:00+00:00","page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-47-marc-lajoie-ceo-at-outpace-bio","show_page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896","url":"https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-47-marc-lajoie-ceo-at-outpace-bio","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/1931877/c1e-o3p3nbvdqz8fmqq3p-kpdmp30mtzj-siytbc.mp3","summary":"\"If you bring powerful technology to a problem that is well understood, then you can really make a difference.\" - Marc Lajoie, CEO at Outpace Bio Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Marc Lajoie, as they discuss how de novo proteins can be used to reprogram immune cells. Tune in today!","meta_description":"\"If you bring powerful technology to a problem that is well understood, then you can really make a difference.\" - Marc Lajoie, CEO at Outpace Bio Welcome…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2905,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-47-marc-lajoie-ceo-at-outpace-bio/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-47-marc-lajoie-ceo-at-outpace-bio.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}